2020 Best of Breast


 

Treatment of Post-Menopausal Woman in the 2nd Line Setting After Progression on CDK4/6 and AI: Data on Alpelisib + Fulvestrant and Other Treatment Options & PARP Inhibitors for gBRCA Mutated BC

482 views
March 2, 2020
Comments 0
Login to view comments. Click here to Login